Merve Alaylıoğlu

863 total citations
33 papers, 700 citations indexed

About

Merve Alaylıoğlu is a scholar working on Physiology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Merve Alaylıoğlu has authored 33 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 13 papers in Pathology and Forensic Medicine and 8 papers in Molecular Biology. Recurrent topics in Merve Alaylıoğlu's work include Alzheimer's disease research and treatments (13 papers), Vitamin D Research Studies (13 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Merve Alaylıoğlu is often cited by papers focused on Alzheimer's disease research and treatments (13 papers), Vitamin D Research Studies (13 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Merve Alaylıoğlu collaborates with scholars based in Türkiye, Greece and Canada. Merve Alaylıoğlu's co-authors include Duygu Gezen‐Ak, Erdinç Dursun, Selma Yılmazer, İrem L. Atasoy, Hakan Gürvıt, Başar Bılgıç, Haşmet Hanağası, Burak Önal, Ömür Selin Araz and Hülya Apaydın and has published in prestigious journals such as Nutrients, Journal of Medical Genetics and Journal of Alzheimer s Disease.

In The Last Decade

Merve Alaylıoğlu

31 papers receiving 681 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Merve Alaylıoğlu Türkiye 11 272 173 166 162 120 33 700
Véréna Landel France 11 230 0.8× 114 0.7× 86 0.5× 310 1.9× 130 1.1× 19 705
Gemma Comes Spain 18 388 1.4× 304 1.8× 150 0.9× 51 0.3× 46 0.4× 28 908
Janaína Kolling Brazil 19 124 0.5× 179 1.0× 98 0.6× 75 0.5× 49 0.4× 44 846
Chuanhan Zhang China 16 316 1.2× 333 1.9× 254 1.5× 79 0.5× 40 0.3× 45 985
Danijela Savić Serbia 18 77 0.3× 205 1.2× 203 1.2× 69 0.4× 57 0.5× 41 678
Jianwei Jiang China 15 310 1.1× 245 1.4× 129 0.8× 56 0.3× 22 0.2× 39 1.0k
Hiroshi Onogi Japan 17 119 0.4× 281 1.6× 76 0.5× 94 0.6× 81 0.7× 32 962
Yumei Zhuang United States 13 139 0.5× 226 1.3× 107 0.6× 52 0.3× 33 0.3× 17 654
Samuel S. Duffy Australia 14 462 1.7× 187 1.1× 184 1.1× 104 0.6× 40 0.3× 15 958

Countries citing papers authored by Merve Alaylıoğlu

Since Specialization
Citations

This map shows the geographic impact of Merve Alaylıoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merve Alaylıoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merve Alaylıoğlu more than expected).

Fields of papers citing papers by Merve Alaylıoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merve Alaylıoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merve Alaylıoğlu. The network helps show where Merve Alaylıoğlu may publish in the future.

Co-authorship network of co-authors of Merve Alaylıoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Merve Alaylıoğlu. A scholar is included among the top collaborators of Merve Alaylıoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Merve Alaylıoğlu. Merve Alaylıoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alaylıoğlu, Merve, Erdi Şahin, Gamze Güven, et al.. (2025). Unravelling the plasma proteome: Pioneering biomarkers for differential dementia diagnosis. Alzheimer s & Dementia. 21(7). e70162–e70162. 1 indexed citations
2.
Küçüksezer, Umut Can, Başar Bılgıç, Merve Alaylıoğlu, et al.. (2025). Association of glycoprotein 1b and miR-26a-5p levels with platelet function in Alzheimer's disease. Journal of Alzheimer s Disease. 105(1). 172–185.
3.
Alaylıoğlu, Merve, Bedia Samancı, Başar Bılgıç, et al.. (2025). Cerebrospinal fluid HSP90AA1, HSPA4, and STUB1/CHIP levels in Alzheimer's disease, mild cognitive impairment, and frontotemporal dementia. Journal of Alzheimer s Disease. 105(2). 481–493. 1 indexed citations
4.
Gezen‐Ak, Duygu, Merve Alaylıoğlu, Cihan İşler, et al.. (2023). Vitamin D receptor regulates transcription of mitochondrial DNA and directly interacts with mitochondrial DNA and TFAM. The Journal of Nutritional Biochemistry. 116. 109322–109322. 23 indexed citations
5.
Dursun, Erdinç, et al.. (2023). A Novel and Robust Protocol for Differentiation of SH-SY5Y Neuroblastoma Cells into Neuron Like Cells. Nöro Psikiyatri Arşivi. 61(3). 208–212. 4 indexed citations
6.
Tüysüz, Beyhan, Merve Alaylıoğlu, Sebuh Kuruğoğlu, et al.. (2022). Biallelic frameshift variants in PHLDB1 cause mild-type osteogenesis imperfecta with regressive spondylometaphyseal changes. Journal of Medical Genetics. 60(8). 819–826. 7 indexed citations
7.
8.
Durmuş, Hacer, Arman Çakar, Merve Alaylıoğlu, et al.. (2021). An Exploratory Study of Cognitive Involvement in Hereditary Transthyretin Amyloidosis. Acta Neurologica Scandinavica. 144(6). 640–646. 7 indexed citations
9.
Gönen, Mustafa Sait, Merve Alaylıoğlu, Yusuf Emre Özdemir, et al.. (2021). Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1. Nutrients. 13(11). 4047–4047. 49 indexed citations
10.
Alaylıoğlu, Merve, et al.. (2021). Protein disulfide isomerase A3 might be involved in the regulation of 24-dehydrocholesterol reductase via vitamin D equilibrium in primary cortical neurons. In Vitro Cellular & Developmental Biology - Animal. 57(7). 704–714. 5 indexed citations
11.
Yılmazer, Selma, Gençer Genç, Merve Alaylıoğlu, et al.. (2020). Low Levels of LRRK2 Gene Expression are Associated with LRRK2 SNPs and Contribute to Parkinson’s Disease Progression. NeuroMolecular Medicine. 23(2). 292–304. 2 indexed citations
12.
Alaylıoğlu, Merve, Erdinç Dursun, Selma Yılmazer, & Duygu Gezen‐Ak. (2020). A Bridge Between in vitro and in vivo Studies in Neuroscience: Organotypic Brain Slice Cultures. Nöro Psikiyatri Arşivi. 57(4). 333–337. 14 indexed citations
13.
Karras, Spyridon Ν., Theocharis Koufakis, Dimitrios G. Goulis, et al.. (2019). Vitamin D receptor Fokl polymorphism is a determinant of both maternal and neonatal vitamin D concentrations at birth. The Journal of Steroid Biochemistry and Molecular Biology. 199. 105568–105568. 9 indexed citations
14.
Dursun, Erdinç, Merve Alaylıoğlu, Başar Bılgıç, et al.. (2019). Amyloid Beta Adsorption Problem with Transfer Plates in Amyloid Beta 1–42 IVD Kits. Journal of Molecular Neuroscience. 67(4). 534–539. 2 indexed citations
15.
Genç, Gençer, Merve Alaylıoğlu, İrem L. Atasoy, et al.. (2019). P1‐200: THE ASSOCIATION BETWEEN VITAMIN D AND THE EXPRESSION OF MITOCHONDRIAL QUALITY CONTROL GENES PINK1 AND PARKIN IN PARKINSON'S DISEASE PATIENTS. Alzheimer s & Dementia. 15(7S_Part_6). 1 indexed citations
16.
Gezen‐Ak, Duygu, et al.. (2018). The Transcriptional Regulatory Properties of Amyloid Beta 1–42 may Include Regulation of Genes Related to Neurodegeneration. NeuroMolecular Medicine. 20(3). 363–375. 19 indexed citations
17.
18.
Gezen‐Ak, Duygu, Merve Alaylıoğlu, Gençer Genç, et al.. (2016). GC and VDR SNPs and Vitamin D Levels in Parkinson’s Disease: The Relevance to Clinical Features. NeuroMolecular Medicine. 19(1). 24–40. 45 indexed citations
19.
Dursun, Erdinç, Merve Alaylıoğlu, Başar Bılgıç, et al.. (2016). Vitamin D deficiency might pose a greater risk for ApoEɛ4 non-carrier Alzheimer’s disease patients. Neurological Sciences. 37(10). 1633–1643. 35 indexed citations
20.
Dursun, Erdinç, Duygu Gezen‐Ak, Haşmet Hanağası, et al.. (2015). The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease. Journal of Neuroimmunology. 283. 50–57. 195 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Véréna Landel Breakdown of academic impact, for papers by Gemma Comes Breakdown of academic impact, for papers by Janaína Kolling Breakdown of academic impact, for papers by Chuanhan Zhang Breakdown of academic impact, for papers by Danijela Savić Breakdown of academic impact, for papers by Jianwei Jiang Breakdown of academic impact, for papers by Hiroshi Onogi Breakdown of academic impact, for papers by Yumei Zhuang Breakdown of academic impact, for papers by Samuel S. Duffy
Rankless by CCL
2026